… markers, as well as novel components of the liquid biopsy, extracellular vesicles (EVs), and
non-coding RNAs for lower limb PAD identification, stratification, and outcome assessment. …

… Asymmetrical dimethylarginine is a known risk marker in vascular disease, inhibiting the NO
synthase and causing endothelial dysfunction, vasoconstriction, elevation of blood pressure…

… ship between inflammatory markers of vascular disorders and … study assessed the relationship
between IMA and inflammatory … Endocan is a novel inflammatory biomarker that may be …

… , as well as traditional and novel potential biomarkers of … blood concentrations of inflammation
markers such as IL-1, IL-6… endothelial dysfunction and inflammation were assessed at the …

… using specific surface markers, adipose vascular stromal cell, … be due to the local inflammatory
signaling that they induce as … uncovered a novel mechanism by which inflammation may …

… -inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte
ratio (PLR) to determine a hemodynamically significant coronary artery stenosis assessed by …

… mellitus on atherosclerotic disease and inflammation. In recent years, the novel concept that
… Further studies are necessary to assess the approach in a model of diabetic vasculopathy. …

… -based medical management, novel drug therapies and … high circulating levels of the
inflammatory marker C-reactive protein (… The analysis also showed that 11 of the 19 loci identified …

… inflammatory status, providing the impetus to develop novel … assessing endothelial function
by a range of traditional and … , calculated as a marker for endothelial function. It should be …

… novel marker, predicts adverse clinical outcomes in coronary … more valuable information in
assessing the severity of CAD … ), history of peripheral artery disease, left ventricular ejection …